Unique TGFBI protein in lattice corneal dystrophy

Area of Science:

• Ophthalmology
• Molecular Biology
• Protein Biochemistry

Background:

• Lattice corneal dystrophy (LCD) is characterized by amyloid deposits, often linked to mutations in the transforming growth factor-beta-induced protein (TGFBIp).
• Specific TGFBIp components contributing to these deposits remain unidentified.
• Mutations like R124C, L518P, and L527R are associated with LCD pathogenesis.

Purpose of the Study:

• To delineate specific TGFBIp components responsible for amyloid deposits in LCD.
• To investigate the role of different TGFBIp mutants in protein aggregation.
• To identify potential biomarkers for LCD through fragment analysis.

Main Methods:

• Generation of recombinant wild-type (WT) TGFBIp and four mutants (R124C, R124H, L518P, L527R) in HEK293FT cells.
• Collection of proteins from cell lysates and purified from culture media.
• Immunoblot analyses using four distinct anti-TGFBIp antibodies targeting various protein regions.

Main Results:

• All TGFBIp monomers and polymers were detected by antibodies, with differential reactivity observed between WT and mutants.
• A 47-kDa band, identified as an N-terminal fragment of L518P mutant TGFBIp, showed universal antibody reactivity.
• A unique 43-kDa band was predominantly detected in R124C and R124H mutants, but not in WT TGFBIp.

Conclusions:

• The 47-kDa protein fragment is likely a ubiquitous N-terminal fragment of the L518P mutant TGFBIp.
• The 43-kDa protein fragment's presence in R124C and R124H mutants suggests its involvement in LCD protein deposits.
• Further research into these specific fragments could elucidate LCD mechanisms and inform therapeutic strategies.